المؤلفون: Borget, I., Tilleul, P., Baud, M., Granghaud, A., Iglesias, E., Chouaid, C.

المساهمون: Annesi-Maesano, Isabella, Epidémiologie des maladies infectieuses et modélisation (ESIM), Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM), Borget I, P Tilleul, M Baud, Granghaud A, E Iglesias, C Chouaid

المصدر: Revue des Maladies Respiratoires
Revue des Maladies Respiratoires, 2007, 24 (1), pp.41-7
Revue des Maladies Respiratoires, Elsevier Masson, 2007, 24 (1), pp.41-7

مصطلحات موضوعية: MESH: Aged, Male, MESH: Anemia, MESH: Humans, MESH: Middle Aged, Lung Neoplasms, MESH: Quality of Life, Anemia, Antineoplastic Agents, Middle Aged, MESH: Male, MESH: Prospective Studies, humanities, MESH: Lung Neoplasms, [SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie, Quality of Life, MESH: Antineoplastic Agents, Feasibility Studies, Humans, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, Female, Prospective Studies, MESH: Feasibility Studies, MESH: Female, Aged

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::19f4c7b0068c7c8a7fcaa3a08f58594bTest
https://pubmed.ncbi.nlm.nih.gov/17268364Test

المؤلفون: Isabelle, Borget, Christos, Chouaid, Nadia, Demarteau, Lieven, Annemans, Jean-Louis, Pujol

المساهمون: Epidémiologie des maladies infectieuses et modélisation (ESIM), Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Department of Public Health, Universiteit Gent = Ghent University (UGENT), Institut de biologie et chimie des protéines [Lyon] (IBCP), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS), Borget I, C Chouaid, N Demarteau, L Annemans, JL Pujol ., Universiteit Gent = Ghent University [Belgium] (UGENT)

المصدر: Bulletin du Cancer
Bulletin du Cancer, 2008, 95 (4), pp.465-73. ⟨10.1684/bdc.2008.0623⟩
Bulletin du Cancer, John Libbey Eurotext, 2008, 95 (4), pp.465-73. ⟨10.1684/bdc.2008.0623⟩

مصطلحات موضوعية: MESH: Anemia, Cost-Benefit Analysis, Antineoplastic Agents, MESH: Drug Administration Schedule, Drug Administration Schedule, Drug Costs, MESH: Hematinics, MESH: Clinical Trials, Phase III as Topic, Neoplasms, MESH: Drug Costs, Confidence Intervals, Humans, Darbepoetin alfa, MESH: Neoplasms, MESH: Erythropoietin, Erythropoietin, health care economics and organizations, Randomized Controlled Trials as Topic, MESH: Models, Economic, MESH: Humans, Anemia, MESH: Confidence Intervals, MESH: France, Models, Economic, MESH: Randomized Controlled Trials as Topic, Clinical Trials, Phase III as Topic, Hematinics, MESH: Antineoplastic Agents, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, France, MESH: Cost-Benefit Analysis

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::dec5a98705eb7265c4cfc94e64fff59dTest
https://hal.sorbonne-universite.fr/hal-00597071Test

المؤلفون: M. Baud, Isabelle Borget, Christos Chouaid, Anne Daguenel, P. Tilleul, Anne Christine Joly

المساهمون: Epidémiologie des maladies infectieuses et modélisation (ESIM), Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Borget I, P Tilleul, M Baud, Joly AC, Daguenel A, C Chouaid .

المصدر: Lung Cancer
Lung Cancer, Elsevier, 2006, 51 (3), pp.369-76. ⟨10.1016/j.lungcan.2005.10.024⟩
Lung Cancer, 2006, 51 (3), pp.369-76. ⟨10.1016/j.lungcan.2005.10.024⟩

مصطلحات موضوعية: Male, Cancer Research, MESH: Anemia, Lung Neoplasms, Darbepoetin alfa, medicine.medical_treatment, Once weekly, 0302 clinical medicine, MESH: Aged, 80 and over, 030212 general & internal medicine, Aged, 80 and over, MESH: Aged, MESH: Middle Aged, Respiratory disease, Anemia, Middle Aged, Markov Chains, 3. Good health, Oncology, 030220 oncology & carcinogenesis, Costs and Cost Analysis, Female, medicine.drug, Adult, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Antineoplastic Agents, MESH: Blood Transfusion, MESH: Drug Administration Schedule, MESH: Costs and Cost Analysis, Drug Administration Schedule, 03 medical and health sciences, MESH: Markov Chains, Internal medicine, medicine, Humans, Blood Transfusion, MESH: Erythropoietin, Lung cancer, Erythropoietin, Aged, Chemotherapy, MESH: Humans, business.industry, MESH: Adult, medicine.disease, MESH: Male, Surgery, MESH: Lung Neoplasms, MESH: Antineoplastic Agents, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, Hemoglobin, business, MESH: Female

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::902158d291365584e99f4c2d0878bdd9Test
https://hal.sorbonne-universite.fr/hal-00597202Test